Literature DB >> 3197979

Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease.

R J Motley1, E O Crawley, C Evans, J Rhodes, J E Compston.   

Abstract

The rate of spinal trabecular bone loss during one year was measured in 54 patients with inflammatory bowel disease. The mean change in spinal bone mineral content was -5.1 mg/ml K2HPO4, representing 3% of the initial bone mineral content. The rate of bone loss showed a significant negative correlation with body mass index (r = -0.276, p less than 0.05) but no other significant correlations were found with other clinical or biochemical indices, including the total amount of prednisolone taken during the course of the study. Eleven patients had bone loss greater than 15 mg/ml/year; these included four non-steroid treated patients, two of whom had disease confined to the large bowel. The results indicate rapid rates of bone loss in some patients with inflammatory bowel disease over the course of one year. Although steroid therapy and malnutrition are likely to be contributory factors in some patients, other, as yet unidentified, risk factors also operate. The rapid bone loss observed in some patients emphasises the need for effective prophylactic regimes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197979      PMCID: PMC1433993          DOI: 10.1136/gut.29.10.1332

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Effect of malabsorption syndrome on calcium metabolism.

Authors:  B E NORDIN
Journal:  Proc R Soc Med       Date:  1961-06

2.  Osteomalacia in sprue.

Authors:  H A SALVESEN; J BOE
Journal:  Acta Med Scand       Date:  1953

3.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

Authors:  T J Hahn; V C Boisseau; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

4.  Effects of kwashiorkor on cortical and trabecular bone.

Authors:  P Adams; F R Berridge
Journal:  Arch Dis Child       Date:  1969-12       Impact factor: 3.791

5.  Calcium balance and bone mineral content following small-intestinal resection.

Authors:  E Hylander; K Ladefoged; S Madsen
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

6.  Quantitative computed tomography for prediction of vertebral fracture risk.

Authors:  C E Cann; H K Genant; F O Kolb; B Ettinger
Journal:  Bone       Date:  1985       Impact factor: 4.398

7.  Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause.

Authors:  B L Riggs; H W Wahner; L J Melton; L S Richelson; H L Judd; K P Offord
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

8.  Long-term reproducibility of bone mineral content measurements.

Authors:  C Christiansen; P Rödbro
Journal:  Scand J Clin Lab Invest       Date:  1977-06       Impact factor: 1.713

9.  Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.

Authors:  C Hendriksen; S Kreiner; V Binder
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

10.  Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.

Authors:  J E Compston; B Creamer
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

View more
  15 in total

1.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Authors:  E M Scott; I Gaywood; B B Scott
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.

Authors:  J Jahnsen; J A Falch; E Aadland; P Mowinckel
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Longitudinal study of bone mineral density in patients with Crohn's disease.

Authors:  D J de Jong; L Mannaerts; L G M van Rossum; F H M Corstens; A H J Naber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

4.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease.

Authors:  J Klaus; G Armbrecht; M Steinkamp; J Brückel; A Rieber; G Adler; M Reinshagen; D Felsenberg; C von Tirpitz
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

6.  Osteoporosis and determinants of bone density in patients with Crohn's disease.

Authors:  R J Robinson; F al-Azzawi; S J Iqbal; T Kryswcki; L Almond; K Abrams; J F Mayberry
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

7.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

8.  Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.

Authors:  Letícia Helena Caldas Lopes; Vera Lucia Sdepanian; Vera Lúcia Szejnfeld; Mauro Batista de Morais; Ulysses Fagundes-Neto
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

9.  Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients.

Authors:  Marina Mauro; Vladimir Radovic; David Armstrong
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

10.  Bone loss in patients with inflammatory bowel disease: a prospective study.

Authors:  C Roux; V Abitbol; S Chaussade; S Kolta; S Guillemant; M Dougados; B Amor; D Couturier
Journal:  Osteoporos Int       Date:  1995-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.